The group injected with CML + PBS exhibited a notably elevated level of IL-6 (19.6 ± 1.3% IL-6-stained area), while the PBS-alone group displayed the lowest stained area (approximately 1.8%). This evidence concerns the gene IL6 and chronic myelogenous leukemia, BCR-ABL1 positive.